U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C25H25N3O8S2
Molecular Weight 559.611
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AGN-201904

SMILES

COC1=CC=C2N(C(=NC2=C1)[S+]([O-])CC3=C(C)C(OC)=C(C)C=N3)S(=O)(=O)C4=CC=C(OCC(O)=O)C=C4

InChI

InChIKey=PPCGSVWOZKNPCX-UHFFFAOYSA-N
InChI=1S/C25H25N3O8S2/c1-15-12-26-21(16(2)24(15)35-4)14-37(31)25-27-20-11-18(34-3)7-10-22(20)28(25)38(32,33)19-8-5-17(6-9-19)36-13-23(29)30/h5-12H,13-14H2,1-4H3,(H,29,30)

HIDE SMILES / InChI

Molecular Formula C25H25N3O8S2
Molecular Weight 559.611
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Allergan was developing the proton pump inhibitor AGN-201904 as an enteric-coated formulation for the treatment of gastric ulcer disease. AGN-201904 is a slowly absorbed, acid-stable pro-proton pump inhibitor (pro-PPI) rapidly converted to omeprazole in the systemic circulation giving a prolonged residence time. AGN-201904 has been used in trials studying the prevention of peptic ulcer.

Approval Year

PubMed

PubMed

TitleDatePubMed
Gateways to clinical trials.
2007 Sep
Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z.
2008 Jul
Patents

Sample Use Guides

AGN-201904 enteric-coated capsules (600 mg/day) or esomeprazole delayed-release tablets (40 mg/day) were administered for 5 days.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 01:24:24 GMT 2023
Edited
by admin
on Sat Dec 16 01:24:24 GMT 2023
Record UNII
G0835O03ZM
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AGN-201904
Common Name English
AGN 201904
Code English
ACETIC ACID, 2-(4-((5-METHOXY-2-(((4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL)SULFINYL)-1H-BENZIMIDAZOL-1-YL)SULFONYL)PHENOXY)-
Common Name English
Code System Code Type Description
CAS
651729-53-2
Created by admin on Sat Dec 16 01:24:24 GMT 2023 , Edited by admin on Sat Dec 16 01:24:24 GMT 2023
PRIMARY
PUBCHEM
9829253
Created by admin on Sat Dec 16 01:24:24 GMT 2023 , Edited by admin on Sat Dec 16 01:24:24 GMT 2023
PRIMARY
FDA UNII
G0835O03ZM
Created by admin on Sat Dec 16 01:24:24 GMT 2023 , Edited by admin on Sat Dec 16 01:24:24 GMT 2023
PRIMARY
DRUG BANK
DB13135
Created by admin on Sat Dec 16 01:24:24 GMT 2023 , Edited by admin on Sat Dec 16 01:24:24 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT